PBLS Parabilis Medicines, Inc.
Price Chart
Executive Summary
Edward M. Fitzgerald filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing stock options and convertible preferred stock holdings in Parabilis Medicines, Inc. This is a routine SEC filing required upon becoming an insider; it contains no material financial events or changes in the company's operations.
Actionable Insight
This is a routine initial ownership filing with no trading or corporate action. No immediate trading signal. Monitor for any subsequent Form 4 filings or IPO-related conversion events.
Key Facts
- Filing type: Form 3 (initial statement of beneficial ownership) filed by Edward M. Fitzgerald.
- Discloses stock options to buy: 16,245 shares at $1.85 (expiring 2027-07-30), 16,245 shares at $4.82 (expiring 2031-05-12), 32,490 shares at $3.14 (expiring 2036-02-23).
- Holds convertible Series B Preferred (5,539 shares common underlying), Series C Preferred (3,878 shares common underlying), and Series F Preferred (5,271 shares common underlying).
- Conversion ratios: Series B 1:1.0389, Series C 1:1.0578, Series F 1:0.6498; all automatically convert to common stock upon IPO closing.
- Filed concurrently with a Limited Power of Attorney designating Teresa Jurgensen and Thomas Kotarakos to execute future Section 16 filings.
Financial Impact
No monetary value disclosed; the options and preferred shares represent insider equity holdings. No transaction or cash flow involved.
Risk Factors
- No material risks identified from this filing alone.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-264573 |
| Document: 0001193125-26-264573-index-headers.html | 0001193125-26-264573 |
| Document: 0001193125-26-264573-index.html | 0001193125-26-264573 |
| Document: 0001193125-26-264573.txt | 0001193125-26-264573 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 16, 2026
4d ago
|
Insider Cluster
| $26.03 $25.85 | ▼ −0.69% | ▼ −1.47% | $25.85 (−0.69%) |
|
Jun 15, 2026
5d ago
|
Insider Cluster
| $26.59 $26.03 | ▼ −2.11% | ▼ −0.86% | $25.85 (−2.78%) |
|
Jun 11, 2026
9d ago
|
8-K
| $27.26 $25.01 | ▼ −8.25% | ▼ −10.02% | $25.85 (−5.17%) |
|
Jun 10, 2026
10d ago
|
424B4
| $30.31 $27.26 | ▼ −10.06% | ▼ −10.60% | $25.85 (−14.71%) |
|
Jun 10, 2026
11d ago
|
EFFECT
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
|
Jun 10, 2026
11d ago
|
3
| $31.60 $30.31 | ▼ −4.08% | ▼ −5.78% | $25.85 (−18.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access